ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system

Chaohui Zuo; Xinyi Sheng; Min Ma; Man Xia; Linda Ouyang

doi:10.18632/oncotarget.11911

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Reviews:

ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system

Chaohui Zuo _, Xinyi Sheng, Min Ma, Man Xia and Linda Ouyang

PDF | HTML | How to cite

Oncotarget. 2016; 7:74393-74409. https://doi.org/10.18632/oncotarget.11911

Metrics: PDF 2569 views | HTML 4222 views | ?

Abstract

Chaohui Zuo1,2, Xinyi Sheng2, Min Ma1, Man Xia3 and Linda Ouyang3

1 Department of Gastroduodenal and Pancreatic Surgery, Translation Medicine Research Center of Liver Cancer, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha, Hunan, China

2 Graduate School, University of South China, Hengyang, Hunan, China

3 Laboratory of Digestive Oncology, Hunan Province Cancer Institute, Changsha, Hunan, China

Correspondence to:

Chaohui Zuo, email:

Keywords: interferon-stimulated gene 15; interferon; tumorigenesis; digestive system; cancer

Received: May 10, 2016 Accepted: September 01, 2016 Published: September 08, 2016

Abstract

The interferon-stimulated gene 15 ubiquitin-like modifier (ISG15) encodes an IFN-inducible, ubiquitin-like protein. The ISG15 protein forms conjugates with numerous cellular proteins that are involved in a multitude of cellular functions, including interferon-induced immune responses and the regulation of cellular protein turnover. The expression of ISG15 and ISG15-mediated conjugation has been implicated in a wide range of human tumors and cancer cell lines, but the roles of ISG15 in tumorigenesis and responses to anticancer treatments remain largely unknown. In this review, we discuss the findings of recent studies with regard to the role of ISG15 pathways in cancers of the digestive system.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 11911

Publication Alerts

Reviews:

ISG15 in the tumorigenesis and treatment of cancer: An emerging role in malignancies of the digestive system

Abstract